WASHINGTON ADVOCACY GROUP

Lobbying for AMGEN INC. · Biotechnology

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $5,000.00 income · posted Jun 12, 2026

Lobbying activity 1

Health Issues

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.